{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:40:41Z","timestamp":1789378841168,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jns.2013.12.026","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T16:01:17Z","timestamp":1387814477000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype\u2013Phenotype analysis of 50 patients"],"prefix":"10.1016","volume":"338","author":[{"given":"Pushpa Raj","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.12.026_bb0005","series-title":"Myology vol 2","first-page":"1697","article-title":"Carnitin palmitoyltransferase deficiency","author":"DiMauro","year":"1986"},{"key":"10.1016\/j.jns.2013.12.026_bb0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/mgme.1999.2938","article-title":"Carnitine palmitoyltransferase deficiencies","volume":"68","author":"Bonefont","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jns.2013.12.026_bb0015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/01.WNL.0000055901.58642.48","article-title":"Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients","volume":"60","author":"Wieser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.12.026_bb0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI115090","article-title":"Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiological approach to carnitine palmitoyltransferase II deficiencies","volume":"87","author":"Demaugre","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2013.12.026_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmitoyltransferase deficiency and myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jns.2013.12.026_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","author":"Corti","year":"2008","journal-title":"J Neurrol Sci"},{"key":"10.1016\/j.jns.2013.12.026_bb0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1005655927639","article-title":"Adult carnitine palmitoyltransferase II deficiency: detection of characteristic carnitine esters in serum by tandem mass spectrometry","volume":"22","author":"Gempel","year":"1991","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.jns.2013.12.026_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s004310100802","article-title":"\u2018Adult\u2019 form of muscular carnitine palmitoyltransferase II deficiency: manifestation in a 2-year-old child","volume":"160","author":"Gempel","year":"2001","journal-title":"Eur J Peadatr"},{"key":"10.1016\/j.jns.2013.12.026_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0887-8994(99)00125-3","article-title":"Muscular carnitine palmitoyltransferase II deficiency in infancy","volume":"22","author":"Hurvitz","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jns.2013.12.026_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.2011.01786.x","article-title":"Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency","volume":"82","author":"Fanin","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.jns.2013.12.026_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1179\/016164110X12767786356390","article-title":"Genotype\u2013phenotype correlations in a large series of patients with muscle type CPT II deficiency","volume":"33","author":"Anachini","year":"2011","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2013.12.026_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0960-8966(99)00096-6","article-title":"Genotype\/Phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compoundheterozygous patient","volume":"10","author":"Thuillier","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jns.2013.12.026_bb0065","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3476(88)80180-X","article-title":"Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle","volume":"112","author":"Reuschenbach","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jns.2013.12.026_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jns.2013.12.026_bb0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","article-title":"Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations","volume":"57","author":"Orngreen","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.12.026_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2013.12.026_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jns.2013.12.026_bb0090","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00415-013-6887-1","article-title":"Expanding mutation spectrum in CPT II gene: identification of four novel mutations","volume":"260","author":"Joshi","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2013.12.026_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1985.tb08913.x","article-title":"Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle","volume":"149","author":"Zierz","year":"1985","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jns.2013.12.026_bb0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng0793-314","article-title":"Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients","volume":"4","author":"Taroni","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2013.12.026_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<210::AID-HUMU5>3.0.CO;2-0","article-title":"Novel mutations associated with carnitine palmitoyltransferase II deficiency","volume":"13","author":"Taggart","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jns.2013.12.026_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/mgme.2001.3281","article-title":"A novel mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency","volume":"75","author":"Deschauer","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jns.2013.12.026_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/humu.10201","article-title":"Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT 2) deficiency","volume":"21","author":"Thuillier","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jns.2013.12.026_bb0120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<941::AID-MUS20>3.0.CO;2-Z","article-title":"Molecular analysis in spanish patients with muscle carnitine palmitoyltransferase deficiency","volume":"22","author":"Martin","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2013.12.026_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<949::AID-MUS23>3.0.CO;2-I","article-title":"Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency","volume":"22","author":"Vladutiu","year":"1999","journal-title":"Muscle Nerve"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13030979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13030979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T21:51:51Z","timestamp":1538949111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13030979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0022510X13030979"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.12.026","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype\u2013Phenotype analysis of 50 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}